Maron Bradley A, Oldham William M, Chan Stephen Y, Vargas Sara O, Arons Elena, Zhang Ying-Yi, Loscalzo Joseph, Leopold Jane A
From the Divisions of Cardiovascular Medicine (B.A.M., S.Y.C., E.A., Y.-Y.Z., J.L., J.A.L.) and Pulmonary and Critical Care Medicine (W.M.O.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Cardiology, Veterans Affairs Boston Healthcare System, Boston, MA (B.A.M.); and Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA (S.O.V.).
Circulation. 2014 Jul 8;130(2):168-79. doi: 10.1161/CIRCULATIONAHA.113.007690. Epub 2014 Apr 28.
The molecular mechanism(s) regulating hypoxia-induced vascular fibrosis are unresolved. Hyperaldosteronism correlates positively with vascular remodeling in pulmonary arterial hypertension, suggesting that aldosterone may contribute to the pulmonary vasculopathy of hypoxia. The hypoxia-sensitive transcription factors c-Fos/c-Jun regulate steroidogenic acute regulatory protein (StAR), which facilitates the rate-limiting step of aldosterone steroidogenesis. We hypothesized that c-Fos/c-Jun upregulation by hypoxia activates StAR-dependent aldosterone synthesis in human pulmonary artery endothelial cells (HPAECs) to promote vascular fibrosis in pulmonary arterial hypertension.
Patients with pulmonary arterial hypertension, rats with Sugen/hypoxia-pulmonary arterial hypertension, and mice exposed to chronic hypoxia expressed increased StAR in remodeled pulmonary arterioles, providing a basis for investigating hypoxia-StAR signaling in HPAECs. Hypoxia (2.0% FiO2) increased aldosterone levels selectively in HPAECs, which was confirmed by liquid chromatography-mass spectrometry. Increased aldosterone by hypoxia resulted from enhanced c-Fos/c-Jun binding to the proximal activator protein-1 site of the StAR promoter in HPAECs, which increased StAR expression and activity. In HPAECs transfected with StAR-small interfering RNA or treated with the activator protein-1 inhibitor SR-11302 [3-methyl-7-(4-methylphenyl)-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid], hypoxia failed to increase aldosterone, confirming that aldosterone biosynthesis required StAR activation by c-Fos/c-Jun. The functional consequences of aldosterone were confirmed by pharmacological inhibition of the mineralocorticoid receptor with spironolactone or eplerenone, which attenuated hypoxia-induced upregulation of the fibrogenic protein connective tissue growth factor and collagen III in vitro and decreased pulmonary vascular fibrosis to improve pulmonary hypertension in vivo.
Our findings identify autonomous aldosterone synthesis in HPAECs attributable to hypoxia-mediated upregulation of StAR as a novel molecular mechanism that promotes pulmonary vascular remodeling and fibrosis.
调节缺氧诱导的血管纤维化的分子机制尚未明确。高醛固酮血症与肺动脉高压中的血管重塑呈正相关,提示醛固酮可能参与缺氧所致的肺血管病变。缺氧敏感转录因子c-Fos/c-Jun调节类固醇生成急性调节蛋白(StAR),后者促进醛固酮类固醇生成的限速步骤。我们推测,缺氧导致的c-Fos/c-Jun上调可激活人肺动脉内皮细胞(HPAECs)中依赖StAR的醛固酮合成,从而促进肺动脉高压中的血管纤维化。
肺动脉高压患者、Sugen/缺氧诱导的肺动脉高压大鼠以及慢性缺氧小鼠的重塑肺小动脉中StAR表达增加,为研究HPAECs中的缺氧-StAR信号通路提供了依据。缺氧(2.0% 吸入氧分数)选择性增加HPAECs中的醛固酮水平,液相色谱-质谱法证实了这一点。缺氧导致醛固酮增加是由于c-Fos/c-Jun与HPAECs中StAR启动子近端激活蛋白-1位点的结合增强,从而增加了StAR的表达和活性。在用StAR小干扰RNA转染或用激活蛋白-1抑制剂SR-11302 [3-甲基-7-(4-甲基苯基)-9-(2,6,6-三甲基环己烯-1-基)壬-2,4,6,8-四烯酸]处理的HPAECs中,缺氧未能增加醛固酮,证实醛固酮生物合成需要c-Fos/c-Jun激活StAR。用螺内酯或依普利酮对盐皮质激素受体进行药理抑制,证实了醛固酮的功能后果,这减弱了缺氧诱导的体外成纤维蛋白结缔组织生长因子和III型胶原的上调,并减轻了体内肺血管纤维化,改善了肺动脉高压。
我们的研究结果确定,HPAECs中因缺氧介导的StAR上调而导致的自主醛固酮合成是促进肺血管重塑和纤维化的一种新的分子机制。